Gemfibrozil and Candidiasis - a phase IV clinical study of FDA data

Summary:

Candidiasis is reported as a side effect among people who take Gemfibrozil (gemfibrozil), especially for people who are male, 40-49 old, also take Levaquin, and have Metastases to bone.

The phase IV clinical study analyzes which people have Candidiasis when taking Gemfibrozil. It is created by eHealthMe based on reports of 17,763 people who have side effects when taking Gemfibrozil from the FDA, and is updated regularly.

What is Gemfibrozil?

Gemfibrozil has active ingredients of gemfibrozil. It is often used in high blood cholesterol. eHealthMe is studying from 18,213 Gemfibrozil users. Check the latest studies of Gemfibrozil.

What is Candidiasis?

Candidiasis (candidiasis or thrush is a fungal infection) is found to be associated with 801 drugs and 1,088 conditions by eHealthMe. Check the latest studies of Candidiasis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

17,763 people reported to have side effects when taking Gemfibrozil.
Among them, 17 people (0.1%) have Candidiasis.

Among these 17 people:

What is the gender of people who have Candidiasis when taking Gemfibrozil? *

female: 47.06 %
male: 52.94 %

What is the age of people who have Candidiasis when taking Gemfibrozil? *

What are other drugs people take besides Gemfibrozil? *

What are other side effects people have besides Candidiasis? *

Pain: 11 people, 64.71%
Sinusitis (inflammation of sinus): 10 people, 58.82%
Arrhythmias (irregular heartbeat): 9 people, 52.94%
Back Pain: 9 people, 52.94%
Nausea And Vomiting: 9 people, 52.94%
Abdominal Pain: 8 people, 47.06%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 8 people, 47.06%
Weight Decreased: 8 people, 47.06%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 47.06%
Dyspnea (difficult or laboured breathing): 8 people, 47.06%

What are the existing conditions these people have? *

Pain: 6 people, 35.29%
Metastases To Bone (cancer spreads to bone): 6 people, 35.29%
Type 2 Diabetes: 2 people, 11.76%
Urinary Tract Infection: 1 person, 5.88%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 5.88%
Stress And Anxiety: 1 person, 5.88%
Sleep Disorder: 1 person, 5.88%
Peripheral Neuropathy (damage to nerves of the peripheral nervous system): 1 person, 5.88%
Multiple Myeloma (cancer of the plasma cells): 1 person, 5.88%
Indigestion: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Gemfibrozil and have Candidiasis?

- Check whether Candidiasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gemfibrozil:

Gemfibrozil (18,213 reports)

Candidiasis treatments and more:

Candidiasis (8,496 reports)

Browse all side effects of Gemfibrozil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Candidiasis:

Candidiasis (801 drugs)

Browse all the conditions that are associated with Candidiasis:

Candidiasis (1,088 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gemfibrozil (the active ingredients of Gemfibrozil) and Gemfibrozil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.